参考文献/References:
[1] 中华医学会骨科学分会.骨质疏松性骨折诊疗指南(2022年版)[J].中华骨科杂志,2022,42(22):1473-1491.
[2] 中国康复医学会骨质疏松预防与康复专业委员会.骨质疏松性椎体压缩骨折诊治专家共识(2021版)[J].中华医学杂志,2021,101(41):3371-3379.
[3] 陈晨,安忠诚,吴连国,等.椎体强化术后早期与后期残留腰背痛的原因分析[J].中国骨伤,2022,35(8):724-731.
[4] 刘晨,胡铖哲,尹逊,等.骨质疏松性胸腰椎压缩骨折经皮椎体强化治疗后残余痛的危险因素[J].中国组织工程研究,2022,26(18):2900-2905.
[5] 刘畅,李大同,刘元,等.急性症状性骨质疏松性胸腰椎压缩骨折椎体强化手术后疗效欠佳:与骨水泥、骨密度、邻近骨折的关系[J].中国组织工程研究,2021,25(22):3510-3516.
[6] 黄天霁,张施洋,鲁超.椎体压缩骨折行椎体强化术后中期止痛效果不佳的原因分析[J].重庆医学,2018,47(34):4403-4405.
[7] 陈晨,安忠诚,张英健,等.椎体强化术后残留腰背痛的研究进展[J].中医正骨,2020,32(5):26-30.
[8] FAN X,LI S,ZENG X,et al.Risk factors for thoracolumbar pain following percutaneous vertebroplasty for osteoporotic vertebral compression fractures[J/OL].J Int Med Res,2021,49(1):300060521989468[2022-12-25].https://pubmed.ncbi.nlm.nih.gov/33513025/.
[9] PERIS P,BLASCO J,CARRASCO J L,et al.Risk factors for the development of chronic back pain after percutaneous vertebroplasty versus conservative treatment[J].Calcif Tissue Int,2015,96(2):89-96.
[10] 田保磊,姚啸生,戚晓楠,等.椎体强化术术后残余腰背痛的影响因素及防治措施[J].中国医药导报,2019,16(32):27-29.
[11] HAAS A V,CONG E,SIMPSON C A,et al.Associations among circulating colony-stimulating factor-1,estrogen,and bone mineral density in postmenopausal women:results from a randomized placebo-controlled trial[J].Menopause,2018,25(2):197-201.
[12] 沈煜,冯明利,徐军,等.老年骨质疏松性椎体压缩性骨折部位和腰椎骨密度对下腰部疼痛的影响[J].中华医学杂志,2016,96(23):1818-1820.
[13] 鲁玉州,王雨,王金国,等.针刺联合常规治疗对骨质疏松性椎体压缩骨折PVP术后残余腰背痛的临床研究[J].湖北中医杂志,2022,44(9):33-36.
[14] PINCUS T,BURTON A K,VOGEL S,et al.A systematic review of psychological factors as predictors of chronicity/disability in prospective cohorts of low back pain[J].Spine(Phila Pa 1976),2002,27(5):E109-120.
[15] YAN Y,XU R,ZOU T.Is thoracolumbar fascia injury the cause of residual back pain after percutaneous vertebroplasty?A prospective cohort study[J].Osteoporos Int,2015,26(3):1119-1124.
[16] 林渺满,文雪梅,黄宗伟,等.骨质疏松性椎体压缩骨折椎体强化术后残余腰背痛风险预测模型的构建与验证[J].中国脊柱脊髓杂志,2022,32(8):720-728.
[17] 王明远,高云,张帅,等.骨质疏松性椎体压缩骨折PVP、PKP并发症防治的进展[J].颈腰痛杂志,2022,43(3):434-436.
[18] HU L,SUN H,WANG H,et al.Cement injection and postoperative vertebral fractures during vertebroplasty[J].J Orthop Surg Res,2019,14(1):228.
[19] 贺双军,吕南宁,刘昊,等.经皮椎体后凸成形术骨水泥分布形态对术后早期疗效的影响[J].中华骨科杂志,2019,39(3):137-143.
[20] 周健,董健.椎体强化手术治疗骨质疏松性脊柱压缩骨折并发症的再认识[J].中国骨伤,2022,35(8):707-709.
[21] ZHANG Z F,LIU D H,WU P Y,et al.Ultra-early injection of low-viscosity cement in vertebroplasty procedure for treating osteoporotic vertebral compression fractures:a retrospective cohort study[J].Int J Surg,2018,52:35-39.
[22] CHEN L H,HSIEH M K,LIAO J C,et al.Repeated percutaneous vertebroplasty for refracture of cemented vertebrae[J].Arch Orthop Trauma Surg,2011,131(7):927-933.
[23] 李秋江,房晓敏,王胤斌,等.骨质疏松性椎体压缩性骨折椎体强化术后椎体再骨折的相关因素[J].中华骨质疏松和骨矿盐疾病杂志,2021,14(3):252-260.
[24] 李正,付军.唑来膦酸和特立帕肽对预防椎体成形术后再发骨折的疗效比较[J].中国骨质疏松杂志,2019,25(7):1002-1005.
[25] 田保磊,姚啸生,戚晓楠,等.椎体强化术后邻椎再发骨折影响因素及预防研究进展[J].中国中医骨伤科杂志,2019,27(1):82-85.
[26] WANG Y T,WU X T,CHEN H,et al.Adjacent-level symptomatic fracture after percutaneous vertebral augmentation of osteoporotic vertebral compression fracture:a retrospective analysis[J].J Orthop Sci,2014,19(6):868-876.
[27] 孟胜伟,蒋盛旦,蒋雷生.胸腰椎骨质疏松性椎体压缩性骨折椎体强化术后腰背痛原因的研究进展[J].脊柱外科杂志,2017,15(2):117-122.
[28] 张永远,孙宏慧,郝定均.脊柱化脓性感染的诊断和治疗进展[J].中国脊柱脊髓杂志,2019,29(8):747-751.
[29] 刘永强,周纪平.Kümmell病的临床研究进展[J].中国矫形外科杂志,2023,31(3):242-246.
[30] 赵鹏,慈元,李志君,等.经椎间孔入路椎体成形术治疗Kümmell病的临床疗效[J].中国脊柱脊髓杂志,2020,30(2):184-188.
[31] 郝定均,刘鹏,贺宝荣,等.陈旧性与新鲜性压缩骨折行椎体成形术的临床对比研究[J].脊柱外科杂志,2012,10(2):83-86.